JP Morgan Chase’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.2M | Sell |
220,166
-24,504
| -10% | -$1.91M | ﹤0.01% | 2261 |
|
|
2025
Q4 | $19.3M | Buy |
244,670
+115,574
| +90% | +$10M | ﹤0.01% | 2094 |
|
|
2025
Q3 | $11.8M | Sell |
129,096
-133,839
| -51% | -$10.9M | ﹤0.01% | 2578 |
|
|
2025
Q2 | $17.2M | Sell |
262,935
-159,815
| -38% | -$10.4M | ﹤0.01% | 2071 |
|
|
2025
Q1 | $28.3M | Buy |
422,750
+154,700
| +58% | +$9.24M | ﹤0.01% | 1652 |
|
|
2024
Q4 | $14.8M | Sell |
268,050
-286,785
| -52% | -$16.5M | ﹤0.01% | 2321 |
|
|
2024
Q3 | $33.1M | Buy |
554,835
+340,854
| +159% | +$20.8M | ﹤0.01% | 1609 |
|
|
2024
Q2 | $13.6M | Sell |
213,981
-18,209
| -8% | -$1.18M | ﹤0.01% | 2180 |
|
|
2024
Q1 | $16.1M | Buy |
232,190
+8,167
| +4% | +$493K | ﹤0.01% | 2072 |
|
|
2023
Q4 | $12.4M | Buy |
224,023
+130,210
| +139% | +$7.17M | ﹤0.01% | 2264 |
|
|
2023
Q3 | $5.45M | Buy |
93,813
+2,601
| +3% | +$150K | ﹤0.01% | 2768 |
|
|
2023
Q2 | $4.91M | Buy |
91,212
+47,673
| +109% | +$2.11M | ﹤0.01% | 2877 |
|
|
2023
Q1 | $1.73M | Buy |
43,539
+4,427
| +11% | +$187K | ﹤0.01% | 3638 |
|
|
2022
Q4 | $1.57M | Buy |
39,112
+3,545
| +10% | +$133K | ﹤0.01% | 3741 |
|
|
2022
Q3 | $1.14M | Buy |
35,567
+156
| +0.4% | +$5.34K | ﹤0.01% | 3898 |
|
|
2022
Q2 | $1.05M | Buy |
35,411
+7,077
| +25% | +$204K | ﹤0.01% | 4038 |
|
|
2022
Q1 | $796K | Sell |
28,334
-3,813
| -12% | -$142K | ﹤0.01% | 4418 |
|
|
2021
Q4 | $1.48M | Sell |
32,147
-2,881
| -8% | -$124K | ﹤0.01% | 4075 |
|
|
2021
Q3 | $1.15M | Sell |
35,028
-19,841
| -36% | -$617K | ﹤0.01% | 4203 |
|
|
2021
Q2 | $1.92M | Sell |
54,869
-3,999
| -7% | -$136K | ﹤0.01% | 3824 |
|
|
2021
Q1 | $2.13M | Buy |
58,868
+5,024
| +9% | +$157K | ﹤0.01% | 3678 |
|
|
2020
Q4 | $1.56M | Buy |
53,844
+46,222
| +606% | +$1.32M | ﹤0.01% | 3662 |
|
|
2020
Q3 | $215K | Buy |
7,622
+891
| +13% | +$26.5K | ﹤0.01% | 4327 |
|
|
2020
Q2 | $217K | Sell |
6,731
-70
| -1% | -$2.51K | ﹤0.01% | 4219 |
|
|
2020
Q1 | $277K | Sell |
6,801
-276
| -4% | -$14.7K | ﹤0.01% | 4131 |
|
|
2019
Q4 | $436K | Sell |
7,077
-64,348
| -90% | -$4.26M | ﹤0.01% | 4302 |
|
|
2019
Q3 | $5.21M | Buy |
71,425
+56,160
| +368% | +$4.2M | ﹤0.01% | 2675 |
|
|
2019
Q2 | $1.21M | Buy |
15,265
+10,822
| +244% | +$770K | ﹤0.01% | 3728 |
|
|
2019
Q1 | $313K | Sell |
4,443
-57,599
| -93% | -$3.39M | ﹤0.01% | 4422 |
|
|
2018
Q4 | $2.79M | Sell |
62,042
-5,671
| -8% | -$297K | ﹤0.01% | 3038 |
|
|
2018
Q3 | $3.83M | Buy |
67,713
+32,314
| +91% | +$1.98M | ﹤0.01% | 2959 |
|
|
2018
Q2 | $2.37M | Buy |
35,399
+4,938
| +16% | +$308K | ﹤0.01% | 3296 |
|
|
2018
Q1 | $1.77M | Sell |
30,461
-22,964
| -43% | -$1.46M | ﹤0.01% | 3336 |
|
|
2017
Q4 | $3.44M | Sell |
53,425
-51,404
| -49% | -$3.2M | ﹤0.01% | 2968 |
|
|
2017
Q3 | $5.4M | Buy |
104,829
+94,002
| +868% | +$4.48M | ﹤0.01% | 2513 |
|
|
2017
Q2 | $507K | Sell |
10,827
-1,552
| -13% | -$74.9K | ﹤0.01% | 3728 |
|
|
2017
Q1 | $612K | Sell |
12,379
-14,050
| -53% | -$789K | ﹤0.01% | 3619 |
|
|
2016
Q4 | $1.6M | Buy |
26,429
+15,896
| +151% | +$972K | ﹤0.01% | 3212 |
|
|
2016
Q3 | $699K | Buy |
10,533
+3,423
| +48% | +$214K | ﹤0.01% | 3285 |
|
|
2016
Q2 | $396K | Buy |
7,110
+6,226
| +704% | +$303K | ﹤0.01% | 3522 |
|
|
2016
Q1 | $30K | Buy |
+884
| New | +$30K | ﹤0.01% | 4006 |
|
Other funds holding ANIP
VCM
SCM
TCM
GAM
DTC
